Skip to content
1st Counsel – Lifestyle
Author:
BioStem Technologies, Inc.
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio
November 12, 2026
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
October 29, 2026
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
October 8, 2026
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
October 1, 2026
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 30, 2026
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
September 18, 2026
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
September 4, 2026
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
BioStem Technologies to Present at the Sidoti MicroCap Conference
August 14, 2026
BioStem Technologies Reports Second Quarter 2026 Financial Results
August 12, 2026
1
2
Next Page
→